BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 3175252)

  • 1. [Effects of age and obesity on the conversion of androstenedione to estrone in postmenopausal women].
    Ortega E; Ruiz E; Osorio C
    Rev Esp Fisiol; 1988 Mar; 44(1):13-6. PubMed ID: 3175252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Origin of serum estradiol in postmenopausal women.
    Judd HL; Shamonki IM; Frumar AM; Lagasse LD
    Obstet Gynecol; 1982 Jun; 59(6):680-6. PubMed ID: 7078905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of Kupperman's index with estrogen and androgen levels, according to weight and body fat distribution in postmenopausal women from Mexico City.
    Carranza-Lira S; Velasco Díaz G; Olivares A; Chán Verdugo R; Herrera J
    Int J Fertil Womens Med; 2006; 51(2):83-8. PubMed ID: 16881384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of estrone and fractional conversion of circulating androstenedione to estrone in women with endometrial carcinoma.
    Rizkallah TH; Tovell HM; Kelly WG
    J Clin Endocrinol Metab; 1975 Jun; 40(6):1045-56. PubMed ID: 1133154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in circulating steroids with aging in postmenopausal women.
    Meldrum DR; Davidson BJ; Tataryn IV; Judd HL
    Obstet Gynecol; 1981 May; 57(5):624-8. PubMed ID: 7219911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer.
    MacDonald PC; Edman CD; Hemsell DL; Porter JC; Siiteri PK
    Am J Obstet Gynecol; 1978 Feb; 130(4):448-55. PubMed ID: 629289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the in vivo conversion of androstenedione to estrone by the aromatase inhibitor vorozole in healthy postmenopausal women.
    van der Wall E; Donker TH; de Frankrijker E; Nortier HW; Thijssen JH; Blankenstein MA
    Cancer Res; 1993 Oct; 53(19):4563-6. PubMed ID: 8402628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difference in segmental lean and fat mass components between pre- and postmenopausal women.
    Douchi T; Yonehara Y; Kawamura Y; Kuwahata A; Kuwahata T; Iwamoto I
    Menopause; 2007; 14(5):875-8. PubMed ID: 17429335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity, hormones, and cancer.
    Kirschner MA; Ertel N; Schneider G
    Cancer Res; 1981 Sep; 41(9 Pt 2):3711-7. PubMed ID: 7260928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The endocrine transition around menopause--a five years prospective study with profiles of gonadotropines, estrogens, androgens and SHBG among healthy women.
    Overlie I; Moen MH; Morkrid L; Skjaeraasen JS; Holte A
    Acta Obstet Gynecol Scand; 1999 Aug; 78(7):642-7. PubMed ID: 10422913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of aging and obesity on aromatase activity of human adipose cells.
    Cleland WH; Mendelson CR; Simpson ER
    J Clin Endocrinol Metab; 1985 Jan; 60(1):174-7. PubMed ID: 3964790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of fasting urinary calcium to circulating estrogen and body weight in postmenopausal women.
    Frumar AM; Meldrum DR; Geola F; Shamonki IM; Tataryn IV; Deftos LJ; Judd HL
    J Clin Endocrinol Metab; 1980 Jan; 50(1):70-5. PubMed ID: 7350188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between estrogens and serum adipocytokines in premenopausal and postmenopausal women.
    Hong SC; Yoo SW; Cho GJ; Kim T; Hur JY; Park YK; Lee KW; Kim SH
    Menopause; 2007; 14(5):835-40. PubMed ID: 17667144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen levels in postmenopausal women with hot flashes.
    Erlik Y; Meldrum DR; Judd HL
    Obstet Gynecol; 1982 Apr; 59(4):403-7. PubMed ID: 7078891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of serum leptin with age, body weight, body mass index, and bone mineral density in healthy mainland Chinese women.
    Zhong N; Wu XP; Xu ZR; Wang AH; Luo XH; Cao XZ; Xie H; Shan PF; Liao EY
    Clin Chim Acta; 2005 Jan; 351(1-2):161-8. PubMed ID: 15563886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of peripheral aromatization of androstenedione to estrone in postmenopausal women with breast cancer using delta 1-testololactone.
    Barone RM; Shamonki IM; Siiteri PK; Judd HL
    J Clin Endocrinol Metab; 1979 Nov; 49(5):672-6. PubMed ID: 489709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of obesity on conversion of plasma androstenedione to estrone in ovulatory and anovulator young women.
    Edman CD; MacDonald PC
    Am J Obstet Gynecol; 1978 Feb; 130(4):456-61. PubMed ID: 629290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of obesity to blood estrogens.
    Zumoff B
    Cancer Res; 1982 Aug; 42(8 Suppl):3289s-3294s. PubMed ID: 7083189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone metabolism: body weight and extraglandular estrogen production.
    Whitworth NS; Meeks GR
    Clin Obstet Gynecol; 1985 Sep; 28(3):580-7. PubMed ID: 4053452
    [No Abstract]   [Full Text] [Related]  

  • 20. Differences in the estrogen content of breast adipose tissue in women by menopausal status and hormone use.
    O'Brien SN; Anandjiwala J; Price TM
    Obstet Gynecol; 1997 Aug; 90(2):244-8. PubMed ID: 9241302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.